Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06282081 · ClinicalTrials.gov registry record
Serum Neurofilament Light in Multiple Sclerosis
A clinical trial of Multiple Sclerosis and Relapsing Remitting Multiple Sclerosis, sponsored by Dent Neuroscience Research Center.
- Active
- Registry status
- 42
- Enrollment target
- 1
- Study location
NCT06282081 is a study of Multiple Sclerosis and Relapsing Remitting Multiple Sclerosis that is active but no longer recruiting, run by Dent Neuroscience Research Center. The registered enrollment target is 42 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06282081, a study of Multiple Sclerosis and Relapsing Remitting Multiple Sclerosis, is active but no longer recruiting, sponsored by Dent Neuroscience Research Center.
- ACTIVE NOT RECRUITING
- Registry status
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective cohort study is designed to characterize the utility of sNfL as a biomarker in clinical practice. This study also aims to understand how access to sNfL measures affects patient and clinician knowledge of their disease status and capture how this may have the potential to influence clinical decision-making. Level of disability, cognitive changes, fatigue, depression, and quality of life to detect clinical and subclinical worsening will be measured. While there is strong evidence in support of sNfL as a potential biomarker, literature regarding the application of sNfL in a real-world clinical practice setting is lacking. Understanding the utility of this test to clinicians and patients as a biomarker of MS disease activity is essential. Additionally, the optimum sampling frequency in clinical practice should be investigated to further elucidate its practicality. Given recent advances in the treatment of MS, there is increasing need for convenient and accessible measures of treatment efficacy.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Serum Neurofilament Light
Study Locations (1)
New York
- Dent Neurologic Institute - Amherst
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2024-04-09 |
| Est. Completion | 2027-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06282081
The ClinicalTrials.gov registry entry for NCT06282081 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The listed sponsor is Dent Neuroscience Research Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Serum Neurofilament Light is the first listed.
NCT06282081 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06282081 about?
NCT06282081 is a clinical study titled "Serum Neurofilament Light in Multiple Sclerosis". This prospective cohort study is designed to characterize the utility of sNfL as a biomarker in clinical practice. This study also aims to understand how access to sNfL measures affects patient and clinician knowledge of their disease status and capture how this may have the potential to influence c...
What is the current status of trial NCT06282081?
This trial is currently active not recruiting. The enrollment target is 42 participants. The study started on 2024-04-09. Estimated completion is 2027-03-01.
What conditions does trial NCT06282081 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis.
What interventions are being tested in trial NCT06282081?
The interventions under investigation include: Serum Neurofilament Light (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06282081?
This trial is sponsored by Dent Neuroscience Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06282081 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.